Patents by Inventor Stephen G. Young

Stephen G. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11090310
    Abstract: This application describes novel therapeutic strategies for treating patients with hypertriglyceridemia and/or chylomicronemia based on the presence of GPIHBP1 autoantibodies. It was unexpectedly found that autoantibodies to GPIHBP1, a GPI anchored protein of capillary endothelial cells that shuttles lipoprotein lipase to its site of action in the capillary lumen, were found to be present in patients with hypertriglyceridemia, and that the autoantibodies blocked the binding of lipoprotein lipase (LPL) to GPIHBP1. Patients having hypertriglyceridemia and/or chylomicronemia and also having GPIHBP1 autoantibodies may be treated with a therapeutically effective amount of an immunosuppressive treatment and/or GPIHBP1 activator.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: August 17, 2021
    Assignee: The Regents of the University of California
    Inventors: Kazuya Miyashita, Stephen G. Young, Anne P. Beigneux, Loren G. Fong, Katsuyuki Nakajima
  • Publication number: 20190160076
    Abstract: The current disclosure relates to a novel therapeutic strategy for patients with hypertriglyceridemia and/or chylomicronemia, wherein the patient is determined to have autoantibodies to GPIHBP1. It was unexpectedly found that autoantibodies to GPIHBP1, a GPI anchored protein of capillary endothelial cells that shuttles lipoprotein lipase to its site of action in the capillary lumen, were found to be present in patients with hypertriglyceridemia, and that the autoantibodies blocked the binding of lipoprotein lipase (LPL) to GPIHBP1. Accordingly, aspects of the disclosure relate to a method for treating hypertriglyceridemia and/or chylomicronemia in a patient comprising administering a therapeutically effective amount of an immunosuppressive treatment and/or GPIHBP1 activator to the patient; wherein the patient has been determined to have GPIHBP1 autoantibodies.
    Type: Application
    Filed: July 28, 2017
    Publication date: May 30, 2019
    Inventors: Kazuya MIYASHITA, Stephen G. YOUNG, Anne P. BEIGNEUX, Loren G. FONG, Katsuyuki NAKAJIMA
  • Patent number: 9170255
    Abstract: Devices and methods that measure one or more properties of a living cell culture that is contained in liquid media within a vessel, and typically analyzes plural cell cultures contained in plural vessels such as the wells of a multiwell microplate substantially in parallel. The devices incorporate a sensor that remains in equilibrium with, e.g., remains submerged within, the liquid cell media during the performance of a measurement and during addition of one or more cell affecting fluids such as solutions of potential drug compounds.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: October 27, 2015
    Assignee: Seahorse Bioscience
    Inventors: Jay S. Teich, Andy C. Neilson, Stephen G. Young, Jim Orrell
  • Publication number: 20140186876
    Abstract: Devices and methods that measure one or more properties of a living cell culture that is contained in liquid media within a vessel, and typically analyzes plural cell cultures contained in plural vessels such as the wells of a multiwell microplate substantially in parallel. The devices incorporate a sensor that remains in equilibrium with, e.g., remains submerged within, the liquid cell media during the performance of a measurement and during addition of one or more cell affecting fluids such as solutions of potential drug compounds.
    Type: Application
    Filed: January 8, 2014
    Publication date: July 3, 2014
    Applicant: Seahorse Bioscience
    Inventors: Jay S. Teich, Andy C. Neilson, Stephen G. Young, Jim Orrell
  • Patent number: 6896144
    Abstract: A filtration apparatus having a plurality of sample wells comprises an upper plate comprising a plurality of upper wells, a lower plate comprising a plurality of lower wells disposed in flexible communication with each other, and a ratcheting mechanism disposed at interfaces of the upper wells and the lower wells. A method for assembling the filtration apparatus comprises supporting the lower plate, disposing a filter medium in the lower well, disposing the upper plate at the lower plate such that the lower wells substantially register with the upper wells, and compressing the upper plate onto the lower plate to form an interference fit between the lower well and the upper well.
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: May 24, 2005
    Assignee: Innovative Microplate
    Inventors: Stephen G. Young, Yevgeniy Margolin
  • Publication number: 20020195386
    Abstract: A filtration apparatus having a plurality of sample wells comprises an upper plate comprising a plurality of upper wells, a lower plate comprising a plurality of lower wells disposed in flexible communication with each other, and a ratcheting mechanism disposed at interfaces of the upper wells and the lower wells. A method for assembling the filtration apparatus comprises supporting the lower plate, disposing a filter medium in the lower well, disposing the upper plate at the lower plate such that the lower wells substantially register with the upper wells, and compressing the upper plate onto the lower plate to form an interference fit between the lower well and the upper well.
    Type: Application
    Filed: June 25, 2002
    Publication date: December 26, 2002
    Inventors: Stephen G. Young, Yevgeniy Margolin
  • Patent number: 5786206
    Abstract: Methods and compositions are described for determining the level of low density lipoproteins (LDL) in plasma. Native apoprotein B-100 (apo B-100) present in LDL particles is immunologically mimicked by a polypeptide of the invention. A polypeptide includes an amino acid residue sequence corresponding to a pan epitope region of the target apoprotein. A preferred polypeptide is a fusion protein that simultaneously mimics native apo B-100 and native apo A-I. Improved assay systems and methods for determining HDL and LDL levels in a body fluid sample are also described.
    Type: Grant
    Filed: October 31, 1994
    Date of Patent: July 28, 1998
    Assignee: The Scripps Research Institute
    Inventors: Richard S. Smith, Linda K. Curtiss, Kanaka Raju Koduri, Joseph L. Witztum, Stephen G. Young
  • Patent number: 5641969
    Abstract: Ion implantation apparatus has an implant wheel in a vacuum chamber. The implant wheel has a number of circumferentially distributed wafer holding positions and is arranged to spin so that the wafers successively intercept an ion beam. The implant wheel is mounted at the free end of a scanning arm which itself is mounted for reciprocating movement on a wall of the vacuum chamber by means of a rotary vacuum seal. A wheel drive motor is mounted in the vacuum chamber on the rotational axis of the implant wheel and the wheel and drive motor combination can be tilted at the end of the scanning arm to adjust the angle of implantation. The tilt actuator is inside the vacuum chamber mounted on the scanning arm and the tilt axis is such that the axis of rotation of the implant wheel remains always in the same plane as the axis of scan of the scanning arm.
    Type: Grant
    Filed: March 28, 1996
    Date of Patent: June 24, 1997
    Assignee: Applied Materials, Inc.
    Inventors: Richard H. Cooke, John J. Perrins, Stephen G. Young
  • Patent number: 5408038
    Abstract: Methods and compositions are described for determining the level of low density lipoproteins (LDL) in plasma. Native apoprotein B-100 (apo B-100) present in LDL particles is immunologically mimicked by a polypeptide of the invention. A polypeptide includes an amino acid residue sequence corresponding to a pan epitope region of the target apoprotein. A preferred polypeptide is a fusion protein that simultaneously mimics native apo B-100 and native apo A-I. Improved assay systems and methods for determining HDL and LDL levels in a body fluid sample are also described.
    Type: Grant
    Filed: October 8, 1992
    Date of Patent: April 18, 1995
    Assignee: The Scripps Research Institute
    Inventors: Richard S. Smith, Linda K. Curtiss, Kanaka R. Koduri, Joseph L. Witztum, Stephen G. Young
  • Patent number: D623300
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: September 7, 2010
    Assignee: Edge Biosystems
    Inventors: Oscar Zimerman, Stephen G. Young